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ed perioperative morbidity and mortality despite pro-
gressive advances in perioperative care and myocardial
protection. We have noted a gradual rise in the preva-
lence of patients referred for reoperative coronary
surgery over the past decade, but this prevalence has
reached a plateau. The risk profile of these patients has,
H ospital morbidity and mortality during coronarybypass operations has decreased substantially dur-
ing the past 2 decades. The overall mortality of coro-
nary bypass surgery at our institution fell from 4.0% in
1982 to 2.2% in 1997. However, patients undergoing
reoperative coronary surgery still face markedly elevat-
Objective: We noted an increasing risk profile of patients undergoing reoper-
ative coronary surgery. We evaluated the risk compared with primary proce-
dures, our results over a 16-year span, and the predictors of hospital out-
comes after redo surgery.
Methods: We analyzed 20,614 patients undergoing isolated coronary surgery
at our institution from 1982 to 1997. Of these, 1230 (6.0%) were undergoing
reoperation. Independent predictors of outcomes were identified by multi-
variable regression.
Results: The prevalence of reoperation peaked in 1994 at 8.2%. Patients
undergoing reoperation were more likely to be male, to have left ventricular
dysfunction and worse symptoms, and to require an urgent operation than
patients undergoing a primary operation (P < .0001). Perioperative myocar-
dial infarctions (3.7% vs 7.4%), low-output syndrome (9.0% vs 24.0%), and
death (2.4% vs 6.8%) were more common in patients undergoing reoperation
(all P < .0001). Over the years, the risk profile of patients undergoing reop-
eration increased. Age, left ventricular dysfunction, severity of symptoms,
extent of coronary artery disease, left main stenosis, and requirement for
urgent or emergency operations increased with time (P < .05). However,
mortality, myocardial infarction, and low-output syndrome have remained
constant. The independent predictors of mortality after reoperative surgery
were increased age, greater Canadian Cardiovascular Society symptom
class, earlier year of operation, and greater left ventricular dysfunction. After
1990, analysis of an expanded data set also identified peripheral vascular dis-
ease and failure to use retrograde cardioplegia as predictors of mortality.
Conclusions: Improving results of reoperative surgery have been offset by an
increasing patient risk profile. Meticulous operative technique and retro-
grade cardioplegia may permit good results in these high-risk patients. 
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however, continued to increase. We therefore attempted
to quantify the changes in the risk profile of patients
requiring reoperation, to evaluate our outcomes, and to
identify the independent predictors of hospital mortali-
ty and morbidity in these patients to permit more accu-
rate risk stratification and to direct further efforts to
improve outcomes.
Methods
Data source. Demographic, anatomic, intraoperative,
and in-hospital outcome data were collected prospectively
and entered into a computerized database on all patients
undergoing cardiac operations at our institution (The
Toronto Hospital, formerly the Toronto General and
Toronto Western Hospitals). From this database, the
records of all patients undergoing reoperative coronary
artery bypass grafting between January 1, 1982, and
December 31, 1997, were retrieved for analysis. Patients
who underwent concomitant valve operations were exclud-
ed, as were those who were undergoing coronary opera-
tions after previous valve operations.
Core fields collected in our database since its inception in
1982 included age, sex, left ventricular (LV) grade (based on
LV ejection fraction [LVEF]: grade 1, LVEF >60%; grade 2,
LVEF 40%-60%; grade 3, LVEF 20%-39%; grade 4, LVEF
<20%), previous coronary artery bypass operation, urgency
of operation (elective; semiurgent, indicating an operation
during the same admission as cardiac catheterization or a car-
diac event; or emergency, indicating an operation within 12
hours of cardiac catheterization or a cardiac event), number of
coronary arteries with significant stenoses, left main stenosis
of greater than 50%, severity of angina, and Canadian
Cardiovascular Society (CCS) symptom class. LVEF was
determined semiquantitatively by contrast ventriculography.
Echocardiography and nuclear ventriculography were carried
out in a minority of patients, and when these additional data
were available, the greatest value for LVEF obtained was
used for subsequent analysis.
Starting in 1990, as we investigated alternative techniques
of cardioplegia, data collection included details of cardiople-
gia temperature (warm [36°C-37°C], tepid [29°C-30°C], or
cold) and continuity (intermittent or continuous), as well as
direction of administration (antegrade, retrograde, or both).
Since 1990, we have also recorded in the database the pres-
ence of particular comorbid conditions, including peripheral
vascular disease, renal failure, chronic obstructive lung dis-
ease, and others. Details of this database, as well as the crite-
ria by which postoperative low-output syndrome was defined,
have been published elsewhere.1
Analysis. Data were collected and managed in dBase IV
data sets and analyzed with SAS and BMDP/DYN LR statis-
tical analysis software (SAS Institute, Inc, Cary, NC; BMDP
Software, Los Angeles, Calif). Univariate analysis of cate-
goric data was carried out with the χ2 or Fisher exact tests.
Univariate analysis of normally distributed continuous vari-
ables was carried out with the Student t test. Univariate analy-
sis of nonnormally distributed continuous variables, such as
length-of-stay parameters, was carried out with a Wilcoxon
rank sum test.
Variables that had a univariate P value of less than .25 or
those of known biologic importance but failing to meet the
critical α level were submitted for consideration to logistic
regression analysis by stepwise selection. Multivariable
logistic regression methods were used to calculate risk-
adjusted mortality and calculate factor-adjusted odds ratios.
Model discrimination was evaluated by the area under the
receiver-operator-characteristic (ROC) curve, and calibration
was assessed with the Hosmer-Lemeshow goodness-of-fit
statistic. For goodness of fit, the null hypothesis is that the
model fits the data. Therefore, a nonsignificant P value is
desired because a P value of less than .05 would indicate a
poor fit between predicted and observed results.
Evaluation of incremental risks caused by reoperation. 
We compared the risk profiles, intraoperative details, and
hospital outcomes of patients undergoing primary versus
reoperative coronary surgery by using χ2 analysis, the Fisher
exact test, or the Student t test as appropriate to assess the
prevalence of risk factors for hospital outcomes and relate
these differences to observed mortality and morbidity in these
2 patient populations.
Evaluation of temporal trends. Rather than constructing
a complex model to assess the temporal trends in prevalence,
risk profiles, and outcomes, we used a simpler approach
based on risk stratification and contingency tables. To exam-
ine the effect of time on patient risk profiles and outcomes,
we divided patients into 3 groups on the basis of the year of
Fig 1. Relative and absolute prevalence of reoperative
surgery in 20,614 patients undergoing coronary bypass oper-
ations from 1982 to 1997. Both the relative and the absolute
prevalence of reoperative coronary surgery peaked in the
early 1990s but have since reached a plateau. CABG,
Coronary artery bypass grafting.
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operation (1982-1986, 1987-1991, or 1992-1997). Con-
tingency table analysis was then used to examine changes in
the prevalence of reoperative operations, risk factors, and
hospital mortality and morbidity over time.
Results
Demographics 
Prevalence of reoperative operation. Of 20,614
patients undergoing isolated coronary bypass opera-
tions at our institution between 1982 and 1997, 1230
(6.0%) were undergoing reoperative surgery. Both the
absolute and relative prevalence of reoperative coro-
nary operation rose from the early 1980s to a high in
1994 before reaching a plateau (Fig 1).
Additional risk factors in patients undergoing reop-
erative surgery. Demographic details of patients under-
going primary or reoperative procedures are listed in
Table I. Patients undergoing reoperative surgery were
more likely to be male, to have worse symptoms, to
have greater LV dysfunction, and to require a more
Table I.  Primary versus reoperative coronary bypass surgery
Primary Primary 
operation Reoperation P value operation Reoperation P value
Demographics
No. of patients 19,384 1230
Male sex 79.7% 86.3% <.0001
Age (y) 60 ± 10 61 ± 9 .02
LVEF








No. of diseased vessels
1 5.5% 5.3% .6
2 22.1% 20.9%
3 72.4% 73.8%
Left main stenosis 16.5% 15.5% .4
Urgency













1982-1997 68.2% 60.2% <.0001
1992-1997 88.9% 64.9% <.0001
Duration of CPB (min) 87 ± 30 102 ± 37 <.0001
Duration of XCL (min) 57 ± 20 62 ± 24 <.0001
Systemic hypothermia






Coronary perfusion 0.2% 0.5% .04
Warm blood cardioplegia 2.8% 2.0%
Tepid blood cardioplegia 5.8% 4.7%
Cold blood cardioplegia 91.2% 92.8%
Outcomes
Mortality 2.4% 6.8% <.0001
Myocardial infarction 3.7% 7.4% <.0001
Low-output syndrome 9.0% 24.0% <.0001
IABP
Preoperative in CCU 3.2% 4.6% <.0001
Preoperative in OR 1.2% 3.6%
Postoperative in OR 3.6% 15.1%
Postoperative in ICU 0.8% 1.0%
Stroke 1.7% 2.4% .08
Reopening





Redo surgery 0.2% 0.4%
Other 0.1% 0.4%
Sternal infection 2.2% 2.9% .1
Duration of ventilation, d
(median [25th-75th percentile])
1990-1994 0.53 1 .0001
[0.23-1] [0.27-1]
1995-1997 0.3 0.32 .1
[0.22-0.45] [0.23-0.54]
ICU stay, d 
(median [25th-75th percentile])
1990-1994 1.9 [1-2] 2 [1-3] .0001
1995-1997 1.1 0.9 .06
[0.9-1.9] [0.9-1.9]
Postoperative hospital stay, d 
(median, [25th-75th percentile])
1990-1994 7 [6-9] 8 [7-10] .0002
1995-1997 7 [6-9] 7 [6-9] .4
LVEF, Left ventricular ejection fraction; CCS, Canadian Cardiovascular Society; LITA, left internal thoracic artery; CPB, cardiopulmonary bypass; XCL, aortic cross-
clamp; IABP, intra-aortic balloon pump; CCU, coronary care unit; OR, operating room; ICU, intensive care unit.
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urgent operation than patients undergoing a primary
operation. These patients were more likely to have had
an intra-aortic balloon placed preoperatively either in
the coronary care unit or in the operating room before
the surgical procedure (Table I). Patient age, the extent
of coronary disease, and the prevalence of left main
coronary artery stenosis were, however, similar
between groups.
Increasing risk profile of patients undergoing reoper-
ation. In more recent years patients undergoing reoper-
ation were older, more symptomatic, more likely to
have triple vessel disease, and more likely to have left
main coronary artery stenosis (Fig 2). The prevalence
of LV dysfunction increased with time, as did the
requirement for an urgent or emergency operation.
Intraoperative data. Intraoperative details, grouped
by primary versus reoperative procedures, are listed in
Table I. Patients undergoing reoperative procedures had
fewer grafts placed than patients undergoing primary
revascularization, despite slightly longer crossclamp
times and substantially longer durations of cardiopul-
monary bypass. Patients undergoing a primary opera-
tion had a left internal thoracic artery (LITA) graft used
routinely. Patients undergoing reoperation were less
likely to have a LITA graft, which may have been relat-
ed to its use at the initial operation, lack of disease in
the left anterior descending coronary artery (LAD), or
the presence of a patent graft to the LAD.
From 1990-1997, cold cardioplegia was still used
most commonly in patients undergoing a reoperative
procedure (coronary perfusion, 0.8%; warm, 3.2%;
tepid, 7.8%; cold, 88.2%). The cardioplegic solution
was given continuously, rather than intermittently, in
31.3% of reoperations compared with 23.6% of prima-
ry procedures (P = .001). Retrograde cardioplegia or a
combination of antegrade and retrograde cardioplegia
was used in 38.8% of reoperations but only 17.9% of
first-time bypass operations (P = .001).
In the early 1990s we abandoned the routine use of
moderate systemic hypothermia during cardiopul-
monary bypass, letting systemic temperatures drift to
approximately 34°C. As a result, from 1990 to 1997,
the lowest systemic temperature during cardiopul-
monary bypass was 36°C to 37°C in 5.0%, 30°C to
35°C in 74.2%, 20°C to 29°C in 20.7%, and less than
20°C in 0.1% of reoperations.
Fig 2. The increasing risk profile of patients undergoing a
reoperative coronary procedure over 3 time periods (1982-
1986, 1987-1991, and 1992-1997). Patient age, symptom
class, extent of coronary artery disease, and the requirement
for urgent or emergency operation all increased significantly
with time. The prevalence of ventricular dysfunction and left
main coronary artery stenosis were also significantly greater
in later years. 3VD, Triple vessel disease; nonelective, urgent
or emergency operation.
Fig 3. Trends in hospital outcomes, including hospital mor-
tality (M), perioperative myocardial infarction (MI), and
postoperative low-output syndrome (LOS), grouped by pri-
mary versus reoperative (redo) operation over 3 time periods
(1982-1986, 1987-1991, and 1992-1997). Over the 16-year
span of this study, hospital mortality, perioperative myocar-
dial infarction, and postoperative low-output syndrome
decreased significantly in patients undergoing first-time coro-
nary bypass operations. In contrast, patients undergoing reop-
erative operations had lesser and nonstatistically significant
improvements in survival and myocardial infarction and no
definite reduction in the prevalence of low-output syndrome.
160 Yau et al The Journal of Thoracic and
Cardiovascular Surgery
July 2000
Outcomes. Overall hospital mortality in patients
undergoing reoperation was almost triple that of
patients undergoing primary revascularization (Table
I). The prevalence of myocardial infarction was dou-
bled and that of postoperative low-output syndrome
was tripled when patients were undergoing reoperation.
Only 4.4% of patients undergoing first-time coronary
bypass grafting required placement of an intra-aortic
balloon pump postoperatively for hemodynamic sup-
port, either in the operating room or in the intensive
care unit, but 16.1% of patients undergoing a reopera-
tion required this mechanical assistance.
In the 742 patients undergoing reoperation from 1990
through 1997, hospital mortality was not significantly
related to cardioplegic temperature (warm, 0%; tepid,
1.7%; cold, 6.57%; P = .084) or to continuity of admin-
istration, but the use of retrograde or combined ante-
grade and retrograde cardioplegia was associated with
a mortality of 3.6% compared with 7.9% in patients
receiving antegrade cardioplegia alone (P = .013).
Mortality was also related to systemic perfusion tem-
peratures (36°C-37°C, 2.7%; 30°C-35°C, 4.2%; 20°C-
29°C, 12.4%; P = .001).
Trends in outcomes over time. Over the 16-year
period of this study, hospital mortality and the preva-
lence of perioperative myocardial infarction and post-
operative low-output syndrome decreased significantly
in patients undergoing primary procedures (Fig 3) but
not in the smaller number of patients undergoing reop-
eration. Hospital mortality was lower in patients under-
going reoperation after 1986, but this difference did not
reach statistical significance.
In 1995 we switched to a “fast-track” perioperative
management strategy, with consequent reductions in
the duration of ventilation and intensive care unit and
hospital stay.2 From 1990 through 1994, the duration of
ventilation and intensive care unit stay were both sig-
nificantly greater in patients undergoing reoperative
coronary procedures than in patients undergoing pri-
mary procedures (Table I). Hospital stay was not, how-
ever, different between these groups. From 1995
through 1997, with the advent of “fast-tracking,” there
were dramatic reductions in both groups in the duration
of ventilation and intensive care unit stay. There was no
significant reduction, however, in hospital length of
stay in patients undergoing reoperation (P = .7091).
Intensive care unit stay and hospital stay remained sig-
nificantly greater in patients undergoing reoperation
(Table I).
Predictors of hospital mortality and low-output
syndrome
Independent predictors of hospital mortality. The
independent predictors of mortality in all 1230 patients
undergoing reoperative coronary surgery were
increased age, greater CCS symptom class, earlier year
of operation, and greater LV dysfunction (Table II).
When this multivariable analysis was repeated, includ-
ing only the 742 patients undergoing reoperation since
1990 in whom analysis of an expanded data set was
possible, the independent predictors of mortality were
greater CCS symptom class (odds ratio, 2.33; 95% con-
fidence interval [CI], 1.16-4.67), greater LV grade
(indicating greater LV dysfunction; odds ratio, 1.99;
95% CI, 1.31-3.01), peripheral vascular disease (odds
Table II.  Multivariable predictors of hospital mortal-
ity in 1230 patients undergoing reoperative coronary
bypass operations from 1982 through 1997
Regression Odds 95%
Variable coefficient ratio CI
Constant –7.5 ± 1.2
Age 0.037 ± 0.015 1.04 1.01–1.07
CCS 0.60 ± 0.23 1.8 1.2–2.8
Year of operation –0.37 ± 0.15 0.69 0.52–0.93
LV grade 0.53 ± 0.14 1.7 1.3–2.2
The area under the ROC curve was 0.69. The Hosmer-Lemeshow goodness-
of-fit P value was .39. LV grade: 1 = LVEF > 60%, 2 = LVEF 40%-60%, 3 =
LVEF 20%-40%, 4 = LVEF < 20%. Urgency: 0 = Elective, 1 = same hospi-
talization, 2 = within 12 hours of a cardiac catheterization or cardiac event (eg,
myocardial infarction and unstable angina). Year of operation: 1 = 1982-1986,
2 = 1987-1991, 3 = 1992-1997.
Table III.  Multivariable predictors of postoperative
low-output syndrome in 1230 patients undergoing
reoperative coronary bypass surgery from 1982
through 1997
Regression Odds 95% 
Variable coefficient ratio CI
Constant –4.4 ± 0.69
Age 0.016 ± 0.0088 1.02 1.00–1.03
Female sex 0.62 ± 0.19 1.9 1.3–2.7
Year of operation –0.24 ± 0.093 0.79 0.66–0.95
LV grade 0.46 ± 0.089 1.6 1.3–1.9
Urgency 0.20 ± 0.11 1.2 0.98–1.5
Left main stenosis 0.35 ± 0.19 1.4 0.98–2.0
Extent of CAD 0.32 ± 0.14 1.4 1.05–1.8
The area under the ROC curve was 0.64. The Hosmer-Lemeshow goodness-
of-fit P value was .61. LV grade: 1 = LVEF >60%, 2 = LVEF 40%-60%, 3 =
LVEF 20%-40%, 4 = LVEF <20%. Urgency: 0 = Elective, 1 = same hospital-
ization, 2 = within 12 hours of a cardiac catheterization or cardiac event (eg,
myocardial infarction or unstable angina). Year of operation: 1 = 1982-1986,
2 = 1987-1991, 3 = 1992-1997. Extent of CAD = number of diseased vessels
(1, 2, or 3).
ratio, 2.43; 95% CI, 1.23-4.81), and failure to use ret-
rograde cardioplegia (odds ratio, 2.74; 95% CI, 1.37-
5.51; area under the ROC curve, 0.729; Hosmer-
Lemeshow goodness-of-fit P value = .6691).
Independent predictors of low-output syndrome.
Preoperative patient variables that were independently
predictive of postoperative low cardiac output syndrome
in all 1230 patients undergoing redo coronary revascu-
larization were increased age, female sex, earlier year of
operation, greater LV dysfunction, greater urgency of
operation, left main coronary artery stenosis, and extent
of coronary atherosclerosis (Table III). In the 742
patients reoperated on between 1990 and 1997, the inde-
pendent predictors of postoperative low-output syn-
drome were female sex (odds ratio, 2.34; 95% CI, 1.47-
3.73), greater LV grade (odds ratio, 1.70; 95% CI,
1.34-2.17), and diabetes (odds ratio, 2.13; 95% CI, 1.38-
3.29; area under the ROC curve, 0.658; Hosmer-
Lemeshow goodness-of-fit P value = .2170).
Discussion
Reoperative coronary bypass operations carry partic-
ular risks over and above those associated with prima-
ry procedures, including the risks associated with a sec-
ond sternotomy and mediastinal dissection (potential
injury to the right ventricle, innominate vein, aorta, and
patent grafts), the greater extent of coronary athero-
sclerosis (associated with a lower number of grafts
placed at reoperation and a higher prevalence of incom-
plete revascularization), and greater technical difficulty
(increasing operative time and the durations of car-
diopulmonary bypass and aortic crossclamping).
Reoperation has been consistently identified as one of
the most significant predictors of increased hospital
mortality and morbidity.1,2 However, cumulative
advances in perioperative anesthetic management and
myocardial protection have progressively reduced the
risk of coronary artery bypass operations, including
that of reoperative procedures.
We found that the prevalence of risk factors that have
consistently predicted hospital mortality and morbidity
in previous studies1-3 increased significantly over the
16-year span of this study. These trends have paralleled
those noted in patients undergoing primary procedures.
In this series hospital mortality in patients undergoing
redo bypass operations decreased from the 1982-1986
to the 1987-1991 cohorts. The prevalence of postoper-
ative low-output syndrome increased, however, during
this period, from approximately 23% to 28%, and the
prevalence of myocardial infarction was unchanged,
suggesting that as the patient risk profile increased,
hospital morbidity also increased, despite the declining
mortality. In the 1990s, as risk profiles increased fur-
ther, both morbidity and mortality remained relatively
constant, although low-output syndrome was slightly
less common.
These findings coincided with a number of changes
in our techniques of perioperative management and
myocardial protection. In the mid-1980s, all surgeons
at our institution adopted a single crossclamp technique
and, in 1987-1988, a terminal “hot shot” of warm blood
cardioplegia as a standard technique of myocardial pro-
tection.4 In the early 1990s, we began a series of inves-
tigations of alternative techniques of cardioplegia that
led to the use, in a subset of patients, of normothermic
or tepid (29°C-30°C) cardioplegia.5-7 However,
because these changes were linked so closely to the
year of operation, it was not possible to isolate the
effects of these factors by multivariable analysis. Other
factors, such as the routine excision of old vein grafts
(except when a LITA graft was placed to a territory
already served by a large but stenotic vein graft)8 have
remained more constant over time.
Analysis of patients undergoing reoperation since
1990, in whom an expanded data set included the tech-
nique of cardioplegia (antegrade, retrograde, or com-
bined antegrade and retrograde), identified the use of
antegrade cardioplegia alone as an independent predic-
tor of mortality after reoperative surgery. Retrograde
cardioplegia may permit more homogeneous delivery
than antegrade cardioplegia to areas of myocardium
supplied by occluded native coronary arteries or bypass
grafts.9,10 In territories perfused by pedicled arterial
grafts, retrograde cardioplegia may be the only means
to deliver cardioplegic solution effectively. In addition,
retrograde cardioplegia may reduce the risk of athero-
matous embolization from diseased vein grafts. Our
data would certainly support the routine use of retro-
grade cardioplegia in patients undergoing reoperative
revascularization.
In our current series no difference was observed
between patients receiving retrograde cardioplegia
alone and a combined technique of antegrade and ret-
rograde cardioplegia. Gundry and colleagues11 have
reported excellent results (a 3% mortality) in 63
patients undergoing a combination of reoperative coro-
nary, valvular, and aortic surgery, which they attribute
to a “no-touch” technique of transatrial cannulation of
the coronary sinus and the avoidance of antegrade car-
dioplegia.
Our recent (1992-1997) prevalence of mortality
(6.3%) and myocardial infarction (6.3%) is consistent
with other published reports. Stephan and colleagues12
reported a mortality of 7.3% in 164 patients undergo-
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ing elective coronary reoperation, with 6.1% of patients
undergoing a Q-wave myocardial infarction. Akl and
colleagues13 reported an 8.3% prevalence of reopera-
tion, with a 5.2% in-hospital mortality from Harefield
Hospital. Fitzgibbon and associates14 reported a mor-
tality of 6.6% in 249 patients undergoing reoperation
and thought that intraoperative graft atheroembolism
was the major cause of morbidity and mortality.14
Shimada and coworkers15 reported outstanding results
in a series of 200 reoperations, with a mortality of only
2.5% and a 0.5% prevalence of re-exploration for post-
operative bleeding.15
The time interval between the first and second oper-
ation may affect the results of reoperation. Schmuziger
and colleagues16 noted a 9.2% mortality in 458 patients
undergoing reoperation in Geneva. In their series mor-
tality was 8.4% in patients requiring reoperation more
than 1 year after the initial procedure but was 28% in
those requiring reoperation in less than a year. In a
series of 508 reoperations, Salomon and colleagues17
reported an overall mortality of 6.9%, but mortality was
lower (6.0%) in patients reoperated on within 10 years
after the initial operation and higher (17.6%) in those
operated on more than 10 years after their first opera-
tion. The necessity for reoperation within a year may be
a marker of technical difficulties at the initial operation
or extensive or rapidly progressive atherosclerosis,
either of which would be expected to increase the risk
of a subsequent operation. In addition, postoperative
mediastinal adhesions are significantly more trouble-
some in this period. Conversely, reoperation more than
10 years after an initial procedure is likely related to
advanced age, which we identified as a predictor of
poor in-hospital outcomes.
Reoperative coronary surgery is now being carried
out under increasingly risky conditions. Mortality has
decreased and then stabilized, whereas perioperative
morbidity has been relatively unchanged. Reducing the
need for coronary reoperation may not be achievable by
current standard therapies, but novel gene transfer
strategies directed at inhibition of vein graft atheroscle-
rosis and induction of native angiogenesis may offer
the promise of one-time-only surgical revasculariza-
tion.
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Discussion
Dr Scot Merrick (San Francisco, Calif). Dr Yau, you and
your colleagues have provided us with a benchmark for reop-
erative coronary surgery. By nature, this is a descriptive
report, and by the size of the study population and the time
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ing redo procedures was higher than that found in primary
cases. With that, can you tell me how you deal with the old
grafts? Do you excise them? Do you leave a graft to the LAD
in place if you are planning on putting an ITA graft on that
vessel? How would you deal with the previously stented ves-
sel?
Dr Yau. We routinely excise all occluded and stenotic vein
grafts. On occasion we will leave in a vein graft that looks
absolutely pristine at reoperation and that is less than 5 years
old. I think that we probably have a lower threshold for
replacing an old vein graft to the LAD territory than we do to
other areas. LAD vein grafts were more likely to be replaced
by another vein graft than by an arterial graft because of con-
cerns about potential hypoperfusion.
Regarding stented coronary arteries, I think that in patients
with native coronary arteries that are now stented from top to
bottom, a combination of angioplasty and repeat grafting may
be useful. That is a problem that obviously is going to arise
with greater frequency as time passes.
Dr Merrick. Thank you. I congratulate you on your mas-
tery of the computer technology. You have shown us how we
should be presenting information at future meetings.
Dr Yau. Thank you.
Dr J. Nilas Young (Berkeley, Calif). Dr Yau, I was inter-
ested to see that the results had somewhat plateaued in more
recent years. Did you analyze the effect of cardiopulmonary
bypass time relative to your results? It is somewhat of an old-
fashioned analysis, but it may have some current relevance,
given the opportunity to do some of these operations off
pump.
Dr Yau. We did look at that in our initial analyses. Both
cardiopulmonary bypass time and aortic crossclamp time
have a significant relation to operative outcomes in these
patients undergoing reoperation. We tend not to present
those factors, however, because except for the case of off-
pump surgery, it is not something that we can identify pre-
operatively or change intraoperatively or use to risk strati-
fy these patients preoperatively. There have certainly been
some very provocative data on early experience with off-
pump coronary reoperations, but we have as yet limited
experience with that.
Dr Steven Guyton (Seattle, Wash). You indicated that the
risk factors had been increasing over time with the redo oper-
ations, and your results perhaps are not particularly better, but
you did not indicate anything about the risk factors in the pri-
mary operations where we do see improving results. We seem
to have seen increasing risk factors in both groups and yet
have been getting results that are equal if not better in both
groups. Do you have any information about risk factors in
your primary operations?
Dr Yau. We have actually documented a similarly increas-
ing risk profile of patients undergoing primary surgery. The
results have, during that time, gradually improved despite
increasing comorbidity and risk factors in the primary
patients.
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interval, it gives us very important information. However, I
still need more information to know what makes a redo oper-
ation high risk. For example, do you have data on how the
type of coronary anatomy at the time of reoperation influ-
ences outcome? Is there a difference between patients with
progression of native disease, graft disease, or prior incom-
plete revascularization?
Dr Yau. We have limited data on those variables in these
1230 patients. As you know, there may be a considerable
overlap in the progression of native disease and graft athero-
sclerosis within territories in a given patient. We have looked
at a subset of 473 of these patients in more detail to try to
clarify the effects of the type of conduit and its patency and
therefore indirectly some of the effects of graft disease on the
outcomes of reoperation. We found that 52% of vein grafts to
the anterior wall were occluded at reoperation, and in the
majority of the patent vein grafts, there was significant dis-
ease. These figures contrasted with approximately 70%
patency at the time of reoperation of arterial grafts to the ante-
rior wall; therefore, there was obviously a significant effect
not only of territory but also of the type of conduit used at the
initial operation. Patency or occlusion of the original graft to
the anterior wall did not have a significant effect on reopera-
tive outcomes in these patients.
Incomplete revascularization is a factor that is unfortunate-
ly difficult to address in this kind of study. Those data were
not gathered prospectively, and only the operating surgeon
knows as he is leaving the operating room how complete or
incomplete that revascularization was. There have been
reports that early reoperation, which may be related either to
incomplete revascularization or to technical difficulties at the
time of the initial procedure, is associated with significantly
increased risk. Schmuziger and colleagues reported that reop-
erations carried out more that a year after the initial operation
carried an 8% mortality, whereas reoperations within the first
year had a 28% mortality. These data, however, give us only
peripheral evidence of that effect.
Dr Merrick. Thank you. I am inclined to believe that reop-
erating on patients with either progressive native disease that
had been previously ungrafted or in patients who have had a
previous incomplete revascularization may be a little bit safer.
Second, did you notice any effect on the time interval
between the primary operation and the redo operation in
terms of the long-term outcome?
Dr Yau. Unfortunately, we do not have complete data on
the late outcomes of these patients other than their need for
reoperation. We were not able to document any differences in
outcomes related to the time between the initial operation and
the second operation.
Dr Merrick. The fact that you did not observe any
improvement in the incidence of reoperative myocardial
infarction and low-output syndrome suggests that intraopera-
tive management may be key. For example, at our Veterans
Administration hospital several years ago, we presented a
study showing that the incidence of myocardial ischemia dur-
